• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.

作者信息

Guo Zhinian, Chen Yunlong, Luo Xiaoyu, He Xiaolong, Zhang Yong, Wang Jiang

机构信息

Department of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.

出版信息

Crit Care. 2020 Jul 11;24(1):420. doi: 10.1186/s13054-020-03142-8.

DOI:10.1186/s13054-020-03142-8
PMID:32653043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7351637/
Abstract
摘要

相似文献

1
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.在重症新型冠状病毒肺炎患者中应用脐带间充质干细胞。
Crit Care. 2020 Jul 11;24(1):420. doi: 10.1186/s13054-020-03142-8.
2
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.人脐带间充质干细胞治疗重症 COVID-19。
Stem Cell Res Ther. 2020 Aug 18;11(1):361. doi: 10.1186/s13287-020-01875-5.
3
Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.静脉输注人脐带华通氏胶源间充质干细胞治疗新型冠状病毒肺炎。
Stem Cell Res Ther. 2020 May 27;11(1):207. doi: 10.1186/s13287-020-01725-4.
4
Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient.脐带血来源的间充质干细胞治疗一名危重症新型冠状病毒肺炎患者
J Infect Dev Ctries. 2020 Oct 31;14(10):1138-1145. doi: 10.3855/jidc.13081.
5
[Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].[间充质干细胞在2019冠状病毒病治疗中的应用——综述]
Sheng Wu Gong Cheng Xue Bao. 2020 Oct 25;36(10):1979-1991. doi: 10.13345/j.cjb.200355.
6
CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia.冠状病毒病（COVID-19）重症肺炎的CT表现
AJR Am J Roentgenol. 2020 May;214(5):W85-W86. doi: 10.2214/AJR.20.23035. Epub 2020 Mar 24.
7
Mesenchymal stem cells as a potential therapy for COVID-19.间充质干细胞作为 COVID-19 的一种潜在疗法。
Stem Cell Res Ther. 2020 May 4;11(1):169. doi: 10.1186/s13287-020-01678-8.
8
Dynamic trajectory of platelet-related indicators and survival of severe COVID-19 patients.重症新型冠状病毒肺炎患者血小板相关指标的动态变化轨迹与生存情况
Crit Care. 2020 Oct 14;24(1):607. doi: 10.1186/s13054-020-03339-x.
9
Severe pulmonary embolism in COVID-19 patients: a call for increased awareness.新冠病毒肺炎患者的严重肺栓塞：呼吁提高认识
Crit Care. 2020 Jun 2;24(1):274. doi: 10.1186/s13054-020-02931-5.
10
[Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].[间充质干细胞治疗COVID-19的进展与挑战]
Sheng Wu Gong Cheng Xue Bao. 2020 Oct 25;36(10):1970-1978. doi: 10.13345/j.cjb.200216.

引用本文的文献

1
Mesenchymal stem cells-derived exosomes alleviate radiation induced pulmonary fibrosis by inhibiting the protein kinase B/nuclear factor kappa B pathway.间充质干细胞衍生的外泌体通过抑制蛋白激酶B/核因子κB通路减轻辐射诱导的肺纤维化。
World J Stem Cells. 2025 Jun 26;17(6):106488. doi: 10.4252/wjsc.v17.i6.106488.
2
The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with infectious diseases and inflammation.外泌体治疗在 COVID-19 中的影响及对未来应对传染病和炎症方法的准备。
Sci Rep. 2024 Mar 8;14(1):5724. doi: 10.1038/s41598-024-56334-5.
3
Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial.多次静脉输注脂肪间充质干细胞治疗住院新冠肺炎患者的安全性：一项随机对照试验。
Front Med (Lausanne). 2023 Dec 22;10:1321303. doi: 10.3389/fmed.2023.1321303. eCollection 2023.
4
Cyclical endometrial repair and regeneration: Molecular mechanisms, diseases, and therapeutic interventions.周期性子宫内膜修复与再生：分子机制、疾病及治疗干预措施
MedComm (2020). 2023 Dec 1;4(6):e425. doi: 10.1002/mco2.425. eCollection 2023 Dec.
5
Mesenchymal Stem Cells in the Treatment of COVID-19.间充质干细胞在治疗 COVID-19 中的作用。
Int J Mol Sci. 2023 Sep 30;24(19):14800. doi: 10.3390/ijms241914800.
6
Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives.间充质干细胞/基质细胞及其分泌组作为附加治疗在严重呼吸道病毒感染中的研究性应用：挑战与展望。
Adv Ther. 2023 Jun;40(6):2626-2692. doi: 10.1007/s12325-023-02507-z. Epub 2023 Apr 17.
7
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.抗原特异性 T 细胞与 SARS-CoV-2 感染：当前方法与未来可能。
Int J Mol Sci. 2022 Dec 1;23(23):15122. doi: 10.3390/ijms232315122.
8
Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.间充质基质细胞治疗急性呼吸窘迫综合征。造血细胞移植后的病例报告及综述。
Front Immunol. 2022 Nov 8;13:963445. doi: 10.3389/fimmu.2022.963445. eCollection 2022.
9
Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review.间充质干细胞疗法治疗新型冠状病毒肺炎患者的临床疗效分析：一项系统评价
World J Clin Cases. 2022 Sep 26;10(27):9714-9726. doi: 10.12998/wjcc.v10.i27.9714.
10
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.间充质干细胞及其衍生的小细胞外囊泡在 COVID-19 治疗中的应用。
Stem Cell Res Ther. 2022 Aug 12;13(1):410. doi: 10.1186/s13287-022-03034-4.

本文引用的文献

1
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.骨髓间充质干细胞来源的外泌体治疗重症 COVID-19。
Stem Cells Dev. 2020 Jun 15;29(12):747-754. doi: 10.1089/scd.2020.0080. Epub 2020 May 12.
2
Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.血管紧张素转换酶2间充质干细胞移植改善新型冠状病毒肺炎患者的预后。
Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.
3
Thinking forward: promising but unproven ideas for future intensive care.未雨绸缪：未来重症监护领域充满希望但未经证实的理念
Crit Care. 2019 Jun 14;23(Suppl 1):197. doi: 10.1186/s13054-019-2462-1.
4
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.间质基质细胞：临床挑战与治疗机遇。
Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004.